CACLP has come to a successful conclusion! WONGENY strives for the future with innovative power

On March 22-24, 2025, the 22nd China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo (CACLP) was grandly held at the Hangzhou Convention and Exhibition Center, with WONGENY showcasing its rich and diverse product line. From molecular diagnostic POCT, real-time fluorescence PCR analyzer, ultrasound disruptor and zebrafish series life science instruments, to the use of microfluidic chip biological consumables, and a fully automated microfluidic chip production line, WONGENY has fully demonstrated its CDMO cross service capability of integrating life science instruments, biological chip consumables, and automation equipment.

01、Empowering precise diagnosis and treatment in all scenarios

02、Shaping a New Future of Precise Diagnosis and Treatment Together

During the exhibition, the booth of WONGENY was crowded with customers from both domestic and foreign markets. Many new and old friends from various industries, as well as medical enterprises and institutions, have come to gain a deeper understanding of product details, technological advantages, and cooperation models. And preliminary intention cooperation was reached with customers from multiple countries such as India, South Korea, Germany, and Russia on site. The partners expressed their appreciation for the international quality and innovative technology of Wanguiyuan products. During the discussion, we found that WONGENY's layout and overall solution CDMO service capabilities are gradually gaining recognition from domestic and international customers.

03、New technology leads life sciences

New technological forces lead towards the future

IVD, and even the entire life sciences industry, is a diagnostic testing market centered around the human body, with diverse demands, multiple interdisciplinary fields, and a small single market. It must rely on industrial division of labor to improve efficiency. This will likely be the future development direction of the domestic IVD industry. Technology becomes a commodity, testing the ability of mass manufacturing. This requires founders with a biological background to have a large manufacturing team that enables products to achieve from 0 to 1, from 1 to 100, and from 100 to 10000. In the future, we will continue to deeply cultivate the field of in vitro diagnostics, and contribute to the cause of human health with higher quality products and services! At the same time, we look forward to working together with more partners to paint a new picture in the fields of laboratory medicine and in vitro diagnostics.

CACLP 2025

· Suzhou WONGENY ·

WONGENY was founded in Suzhou in 2018 and is a pioneer in fully automated production of microfluidic chips worldwide. Belonging to the "National High tech Enterprise" and "Unicorn Cultivation Enterprise", it is a key investment enterprise of Suzhou Municipal Government and has received multiple rounds of investment from Suzhou State owned Assets and Marketization Fund. After years of research and development accumulation, we currently have the OEM/ODM/CDMO service capability that integrates "life science instruments+biochar consumables+automated production equipment", which can meet customers' multi-dimensional needs for research and development, manufacturing, and production. Our service areas cover in vitro diagnostics, medical devices, life sciences, biomedicine, etc. We specialize in the research and development, manufacturing, production process development, mold manufacturing, and mass production services of high-value biological consumables and life science instruments represented by microfluidic chips. We also provide customers with high-quality services in molecular testing, cell culture, immunotherapy, biopharmaceuticals, medical devices, and other areas.